|
Market Cap (22-Jun) $292,012,800 (943rd) |
Close (30-Jun) $0.350 |
Volume (30-Jun) 313,271 |
Shortsold (6-Jun) 238,849 (0.10%) (425th) |
|
52w High $1.79 |
52w Low $0.350 |
P/E - |
EPS -0.02 |
OCC released this announcement to the ASX on 23 November 2020, 18:41. The announcement is not marked as price sensitive, and is 12 page(s) in length and 433.84kb in size.
You can view all announcements from OCC and see how they appear on a price chart on the announcements page.
At the date of this announcement, OCC was 0.766% short sold according to ASIC data. It was ranked the 235th most shorted stock on the ASX. It remains ranked 425th as of the latest reported data (06 June 2025).
| Other Recent Announcements from OCC | |
|---|---|
| Orthocell receives A$3.17m R&D tax incentive refund | 21 June 2023, 9:00 |
| Change of Director's Interest Notice - Paul Anderson | 16 June 2023, 9:08 |
| Change of Director's Interest Notice - Paul Anderson | 13 June 2023, 9:25 |
| Change of Director's Interest Notice * 4 | 23 November 2020, 18:41 |
| Positive Results in CelGro Nerve Repair Study | 20 November 2020, 9:52 |
| Trading Halt | 18 November 2020, 9:36 |
| Appendix 4C - Quarterly | 29 October 2020, 17:58 |
You must be logged in to post a reply.
Orthocell 